74 related articles for article (PubMed ID: 9286070)
1. Cardiac rehabilitation and risk factor management after myocardial infarction. Clinical and economic evaluation.
Oldridge NB
Wien Klin Wochenschr; 1997; 109 Suppl 2():6-16. PubMed ID: 9286070
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive cardiac rehabilitation: is it cost-effective?
Oldridge NB
Eur Heart J; 1998 Nov; 19 Suppl O():O42-50. PubMed ID: 9857950
[TBL] [Abstract][Full Text] [Related]
3. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
Wachtel TM; Kucia AM; Greenhill JA
Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
[TBL] [Abstract][Full Text] [Related]
4. A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction.
Lamotte M; Annemans L; Kawalec P; Zoellners Y
Herz; 2006 Dec; 31 Suppl 3():74-82. PubMed ID: 17575809
[TBL] [Abstract][Full Text] [Related]
5. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
[TBL] [Abstract][Full Text] [Related]
7. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
Fidan D; Unal B; Critchley J; Capewell S
QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875
[TBL] [Abstract][Full Text] [Related]
8. Integrating cost-effectiveness evidence into clinical practice guidelines in Australia for acute myocardial infarction.
Antioch KM; Jennings G; Botti M; Chapman R; Wulfsohn V
Eur J Health Econ; 2002; 3(1):26-39. PubMed ID: 15609115
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care.
Turner DA; Paul S; Stone MA; Juarez-Garcia A; Squire I; Khunti K
Heart; 2008 Dec; 94(12):1601-6. PubMed ID: 18450843
[TBL] [Abstract][Full Text] [Related]
10. Achievement of secondary preventive goals after acute myocardial infarction: a comparison between participants and nonparticipants in a routine patient education program in Sweden.
Bellman C; Hambraeus K; Lindbäck J; Lindahl B
J Cardiovasc Nurs; 2009; 24(5):362-8. PubMed ID: 19652617
[TBL] [Abstract][Full Text] [Related]
11. A National Health Service Hospital's cardiac rehabilitation programme: a qualitative analysis of provision.
O'Driscoll JM; Shave R; Cushion CJ
J Clin Nurs; 2007 Oct; 16(10):1908-18. PubMed ID: 17880480
[TBL] [Abstract][Full Text] [Related]
12. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
13. Computerised systematic secondary prevention in ischaemic heart disease: a study in one practice.
Starkey C; Michaelis J; de Lusignan S
Public Health; 2000 May; 114(3):169-75. PubMed ID: 10878743
[TBL] [Abstract][Full Text] [Related]
14. Need cardiac rehabilitation be cost-effective?
Perk J
J Cardiovasc Risk; 1996 Apr; 3(2):167-71. PubMed ID: 8836858
[TBL] [Abstract][Full Text] [Related]
15. Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease.
Vale MJ; Jelinek MV; Best JD; Dart AM; Grigg LE; Hare DL; Ho BP; Newman RW; McNeil JJ;
Arch Intern Med; 2003 Dec 8-22; 163(22):2775-83. PubMed ID: 14662633
[TBL] [Abstract][Full Text] [Related]
16. Home-based cardiac rehabilitation versus hospital-based rehabilitation: a cost effectiveness analysis.
Taylor RS; Watt A; Dalal HM; Evans PH; Campbell JL; Read KL; Mourant AJ; Wingham J; Thompson DR; Pereira Gray DJ
Int J Cardiol; 2007 Jul; 119(2):196-201. PubMed ID: 17084927
[TBL] [Abstract][Full Text] [Related]
17. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
Krummenauer F; Günther KP; Witzlebf WC
Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based, cost-effective risk stratification and management after myocardial infarction. California Cardiology Working Group on Post-MI Management.
Deedwania PC; Amsterdam EA; Vagelos RH
Arch Intern Med; 1997 Feb; 157(3):273-80. PubMed ID: 9040293
[TBL] [Abstract][Full Text] [Related]
19. [The cost-benefit of cardiac rehabilitation programs].
Coll R
Rev Esp Cardiol; 1995; 48 Suppl 1():94-8. PubMed ID: 7644830
[TBL] [Abstract][Full Text] [Related]
20. Impact of worksite wellness intervention on cardiac risk factors and one-year health care costs.
Milani RV; Lavie CJ
Am J Cardiol; 2009 Nov; 104(10):1389-92. PubMed ID: 19892055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
